JAC Advance Access originally published online on January 25, 2006
Journal of Antimicrobial Chemotherapy 2006 57(3):569-572; doi:10.1093/jac/dkl002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reduction in fluoroquinolone susceptibility among non-typhoidal strains of Salmonella enterica isolated from Finnish patients
1 Antimicrobial Research Laboratory, Department of Bacterial and Inflammatory Diseases, National Public Health Institute, Kiinamyllynkatu 13, 20521 Turku, Finland; 2 Department of Medicine, Turku University Hospital, Kiinamyllynkatu 4-8, 20520 Turku, Finland; 3 Enteric Bacteria Laboratory, Department of Bacterial and Inflammatory Diseases, National Public Health Institute, Mannerheimintie 166, 00300 Helsinki, Finland
Received 19 October 2005; returned 6 December 2005; revised 11 December 2005; accepted 23 December 2005
* Corresponding author. Tel: +358-2-3316600; Fax: +358-2-331-6699; E-mail: antti.hakanen{at}utu.fi
Objectives: The proportion of Salmonella isolates with reduced susceptibility to fluoroquinolones has increased during recent years in many countries, especially in South-east Asia. The present study was performed to evaluate the incidence of and changes in quinolone resistance in Salmonella isolates of either foreign or domestic origin in Finland.
Methods: A total of 1004 Salmonella isolates collected from Finnish patients between 2000 and 2004 were analysed for ciprofloxacin susceptibility. Of these isolates, 504 were of domestic origin and 500 were of foreign origin, collected from travellers to 43 different countries. The Salmonella collection consisted of 89 different serotypes. All isolates belonged to non-typhoidal Salmonella enterica.
Results: Of all isolates, 3 (0.3%) were ciprofloxacin-resistant (MIC 
4 mg/L) and 214 (21.3%) exhibited reduced susceptibility to ciprofloxacin (MIC 0.125–2 mg/L). The annual proportion of reduced susceptibility varied between 3 and 15% among the domestic Salmonella isolates (P = 0.123). Between 2000 and 2004, the annual proportion of reduced susceptibility increased significantly (from 23 to 39%; P = 0.001) among all foreign isolates as well as among those from Spain alone (from 4 to 73%; P < 0.001). Among the isolates from Thailand, reduced ciprofloxacin susceptibility remained at a constantly high level (52–66%) throughout the study.
Conclusions: Our results show that reduced fluoroquinolone susceptibility in S. enterica is not restricted to South-east Asia alone but continues to grow rapidly in many parts of the world including countries of the European Union.
Keywords: salmonella , quinolones , ciprofloxacin , drug resistance , enteric bacteria
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Gunell, M. A. Webber, P. Kotilainen, A. J. Lilly, J. M. Caddick, J. Jalava, P. Huovinen, A. Siitonen, A. J. Hakanen, and L. J. V. Piddock Mechanisms of Resistance in Nontyphoidal Salmonella enterica Strains Exhibiting a Nonclassical Quinolone Resistance Phenotype Antimicrob. Agents Chemother., September 1, 2009; 53(9): 3832 - 3836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kehrenberg, A. de Jong, S. Friederichs, A. Cloeckaert, and S. Schwarz Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations J. Antimicrob. Chemother., May 1, 2007; 59(5): 886 - 892. [Abstract] [Full Text] [PDF]
|
|